BMJ open · 2025
Classification of kinesiophobia in patients after cardiac surgery under extracorporeal circulation in China: latent profile and influencing factors analysis from a cross-sectional study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Xing Wenhui, Piao Jing Jing, Ren Tong, Liang Yujing, Li Qi, Gu Yanmei, Wang Rong
Аннотация
OBJECTIVE: To investigate the potential classification of kinesiophobia in patients after cardiac surgery under extracorporeal circulation from a psychosocial perspective, and analyse the characteristic differences among different latent levels of patients.
STUDY DESIGN: This is a cross-sectional study of Chinese adults after cardiac surgery under extracorporeal circulation, aged 18 years and older, recruited from a tertiary hospital in North China.
METHODS: This study uses latent profile analysis to identify potential classifications of kinesiophobia in questionnaires from 348 patients undergoing cardiac surgery under extracorporeal circulation. Multiple logistic regression analysis was used to evaluate the influencing factors at different latent classifications.
RESULTS: The average performance of each indicator in Model 3 is best suited for analysis, Entropy=0.873 and bootstrap likelihood ratio test (p)＜0.0001. The result of regression equation shows postoperative time (p<0.001), age, self-efficacy, pain and social support level (p<0.05) were the factors influencing the potential profile classification of patients after cardiac surgery under extracorporeal circulation.
CONCLUSION: The study identified three distinct classifications of patients: the low kinesiophobia group, the moderate kinesiophobia-high-risk perceived symptoms group and the high kinesiophobia-high exercise avoidance group (HK-HEAG). Addressing kinesiophobia, especially in older male patients during the early postoperative period, is crucial. Enhancing self-efficacy seems effective in reducing kinesiophobia, while increasing social support may not be as beneficial for the HK-HEAG. These findings provide a basis for implementing preventive interventions in cardiac rehabilitation.
TRIAL REGISTRATION NUMBER: The research is registered with the Chinese Clinical Trial Registry (ChiCTR2200057895).
STUDY DESIGN: This is a cross-sectional study of Chinese adults after cardiac surgery under extracorporeal circulation, aged 18 years and older, recruited from a tertiary hospital in North China.
METHODS: This study uses latent profile analysis to identify potential classifications of kinesiophobia in questionnaires from 348 patients undergoing cardiac surgery under extracorporeal circulation. Multiple logistic regression analysis was used to evaluate the influencing factors at different latent classifications.
RESULTS: The average performance of each indicator in Model 3 is best suited for analysis, Entropy=0.873 and bootstrap likelihood ratio test (p)＜0.0001. The result of regression equation shows postoperative time (p<0.001), age, self-efficacy, pain and social support level (p<0.05) were the factors influencing the potential profile classification of patients after cardiac surgery under extracorporeal circulation.
CONCLUSION: The study identified three distinct classifications of patients: the low kinesiophobia group, the moderate kinesiophobia-high-risk perceived symptoms group and the high kinesiophobia-high exercise avoidance group (HK-HEAG). Addressing kinesiophobia, especially in older male patients during the early postoperative period, is crucial. Enhancing self-efficacy seems effective in reducing kinesiophobia, while increasing social support may not be as beneficial for the HK-HEAG. These findings provide a basis for implementing preventive interventions in cardiac rehabilitation.
TRIAL REGISTRATION NUMBER: The research is registered with the Chinese Clinical Trial Registry (ChiCTR2200057895).